Kakuta, Takatoshi
Sawada, Kaichiro
Kanai, Genta
Tatsumi, Ryoko
Miyakogawa, Takayo
Ishida, Mari
Nakazawa, Raima
Fukagawa, Masafumi
Article History
Received: 20 September 2019
Accepted: 20 January 2020
First Online: 24 February 2020
Competing interests
: T.K. has received honoraria from the Kyowa Kirin Co.ltd and Chugai Pharmaceutical. M.F. has acted as a consultant for the Kyowa Kirin Co.ltd, Bayer Japan, and Novartis; has received honoraria from the Kyowa Kirin Co.ltd, Chugai Pharmaceutical, Bayer Yakuhin, Novartis, Genzyme, and Abbot Japan; and has received grants/research support from the Kyowa Kirin Co.ltd, Chugai Pharmaceutical, and Bayer Yakuhin. The other authors declare that they have no relevant financial interests.